The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and BOOST&Co loan facility update

13 Oct 2021 07:00

RNS Number : 8656O
Falanx Group Limited
13 October 2021
 

13 October 2021

FALANX GROUP LIMITED

("Falanx", the "Group" or the "Company")

Trading update

and

BOOST&Co loan facility update

Falanx Group Limited (FLX.L), the AIM listed cyber security business, is pleased to update on trading for the six months period to 30 September 2021, and to announce further strengthening of its cash position.

 

Cyber Security Division Trading Update for the six months to 30 September 2021

 

The division won sales orders of over £2.5m (2020: £1.5m). This supported revenue growth of 29% to £1.8m (2020: £1.4m) and increased the gross margin to 40% (2020: 27%). Consequently, the division has recorded an adjusted EBTIDA profit of c£0.1m (2020: £0.28m loss). The Cyber division is now profitable on a routine monthly basis at an adjusted EBITDA level.

 

Second Tranche of BOOST&Co Loan

 

Falanx is pleased to announce that it has received the final £1.5m balance under its £2.5m loan facility with BOOST&Co (the "Loan").

 

The proceeds of the Loan, together with the net proceeds of the recent sale of the Group's Assynt division, will be used for potential earnings enhancing acquisitions within cyber security and also for organic investment into sales and marketing, ongoing product innovation as well as overall balance sheet strength.

 

The key terms of the Loan are:

· £2.5m facility secured over the Group's assets

· Annual interest of 11% and straight-line amortisation of the loan commencing after 12 months

· The loan carries a 3% early prepayment fee on the then amount outstanding

 

Following receipt of the Loan, Falanx has its strongest ever cash position, with current balances of over £5.5m following the adjustments referenced in the announcement of 6 October 2021. Net (of Loan) cash is currently £3.0m.

 

Further details on the BOOST&Co loan are contained in the Company's announcement on 18 August 2021. The Company's announcement on 29 September 2021 includes further details on the Group's current trading.

 

Alex Hambro (Non-Executive Chairman) said: "The receipt of this final tranche of funds from BOOST & Co completes the strategic repositioning of Falanx into a well-resourced "pure play" in the emerging field of cyber security service provision to UK SMEs. With the recent disposal of our strategic business intelligence division, we can now focus on the 24/7 protection of our clients with our Triarii technology platform and the seamless onboarding of future clients that will emerge from our channel partners."

 

"Both our financial performance and position have markedly improved, and I am confident in Falanx's new direction and future."

 

 

Enquiries:

 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Alex Price / Fred Walsh

+ 44 (0) 207 710 7600

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

 

+44 (0) 203 934 663

 

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: https://www.falanx.com/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPGMUUUPGGBP
Date   Source Headline
18th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20212:05 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:06 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSTriarii to include Microsoft Azure Sentinel
18th Dec 20207:00 amRNSUpdate on SolarWinds® Orion® Platform Cyberattack
17th Dec 20202:28 pmRNSResult of AGM
17th Dec 20207:00 amRNSInterim results
1st Dec 20207:00 amRNSTotal Voting Rights
23rd Nov 202010:12 amRNSNotice of AGM
4th Nov 20204:42 pmRNSDirector subscriptions/PDMR dealing and TVR
30th Oct 20204:17 pmRNSPublication of final results & total voting rights
30th Oct 20207:00 amRNSPreliminary results for year ended 31 March 2020
28th Oct 20207:00 amRNSFalanx joins SolarWinds TAP
2nd Oct 20201:53 pmRNSHolding(s) in Company
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20202:21 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSConfirmation of successful fundraising
28th Sep 20204:55 pmRNSProposed Equity Fundraise
18th Sep 20207:00 amRNSStrategic Contract Win
21st Aug 202012:16 pmRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSStrategic Contract Win
5th Aug 20207:00 amRNSTrading Statement
24th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20207:00 amRNSHolding(s) in Company
9th Jul 20202:19 pmRNSHolding(s) in Company
21st Apr 20207:00 amRNSSalary sacrifice, grant of options & PDMR dealing
27th Feb 202011:56 amRNSHolding(s) in Company
2nd Jan 20203:21 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSSale of Furnace and Directorate Change
3rd Dec 20194:40 pmRNSResult of AGM
3rd Dec 20197:00 amRNSInterim Results
22nd Nov 201910:18 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSTrading update, notice of results & notice of AGM
25th Sep 20197:30 amRNSGrant of Share Options
25th Sep 20197:00 amRNSDirector/PDMR Shareholding
24th Sep 201911:37 amRNSDirector/PDMR Shareholding
23rd Sep 20193:13 pmRNSAvailability of report and accounts
19th Sep 20197:00 amRNSAnnual results for the year ended 31 March 2019
31st May 201911:39 amRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSChange of Adviser
28th Mar 20197:00 amRNSDirectorate Change
22nd Mar 20197:00 amRNSChange of Adviser
18th Feb 201910:32 amRNSDirector / PDMR Shareholding
18th Feb 201910:18 amRNSDirector / PDMR Shareholding
21st Dec 20181:01 pmRNSGrant of Share Options
21st Dec 201812:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.